Characteristic | Total (%) (n=380) | Follow-up visit recommended (%) (n=347) | Follow-up visit attended (%) (n=253) |
Age (years) | |||
<30 | 55.0 | 55.0 | 55.3 |
≥30 | 45.0 | 45.0 | 44.7 |
Race | |||
White | 62.3 | 61.3 | 64.3 |
Black | 18.7 | 18.8 | 16.3 |
Other | 19.0 | 19.9 | 19.4 |
Married | 41.3 | 41.5 | 38.9 |
Parity* | |||
0 | 35.2 | 35.9 | 39.4 |
≥1 | 64.8 | 64.1 | 60.6 |
First IUD (%)* | 77.9 | 79.0 | 82.2 |
Type of IUD (%) | |||
LNG IUS 52 µg/LNG IUS 13.5 µg (Mirena/Skyla) | 90.5 | 91.1 | 91.7 |
Copper T 380A (ParaGard) | 9.5 | 8.9 | 8.3 |
No prior contraception | 37.4 | 38.6 | 39.1 |
*Women with no children (p=0.015, compared with women with one or more children) and women receiving their first IUD (p=0.004) were more likely to attend a 6-week follow-up visit.
IUD, intrauterine device; IUS, intrauterine system.